Neoplastic Processes  >>  oxaliplatin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00510627: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Withdrawn
4
0
US
Radiofrequency Ablation (RFA), RF3000 Radiofrequency (RF) Generators, LeVeen Electrode, Co-Access Electrode, Soloist Electrode, SuperSlim Electrode, Chemotherapy, Oxaliplatin containing chemotherapy regimen, Irinotecan containing chemotherapy regimen, An anti-EGFR monoclonal antibody-containing regimen, Other
Boston Scientific Corporation
Metastatic Liver Cancer, Secondary Liver Cancer, Liver Neoplasm
 
12/10
NCT00577031 / 2007-004969-18: OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Checkmark Data-ESMO
Sep 2011 - Sep 2011: Data-ESMO
Completed
4
205
Europe
bevacizumab [Avastin], Oxaliplatin, Xeloda
Hoffmann-La Roche
Colorectal Cancer
08/11
08/11

Download Options